Fonar (FONR) P/E (2011 - 2026)
Fonar (FONR) P/E from Sep 30, 2011 to Jun 3, 2026. The TTM Fonar (FONR) P/E is 15.47. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Fonar (FONR)
| Year | P/E | Change |
|---|---|---|
| 2026 | 15.47 | +6.29% |
| 2025 | 14.56 | +56.56% |
| 2024 | 9.30 | -10.07% |
| 2023 | 10.34 | +15.40% |
| 2022 | 8.96 | +36.27% |
| 2021 | 6.57 | -41.42% |
| 2020 | 11.22 | +23.10% |
| 2019 | 9.12 | +3.69% |
| 2018 | 8.79 | +1.90% |
| 2017 | 8.63 | -3.94% |
| 2016 | 8.98 | -5.12% |
| 2015 | 9.47 | +36.98% |
| 2014 | 6.91 | -62.01% |
| 2013 | 18.20 | +296.19% |
| 2012 | 4.59 | -29.78% |
| 2011 | 6.54 | N/A |
Comparison Fonar (FONR) P/E with competitors
Fonar (FONR) P/E is 15.47.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| ADVB | Advanced Biomed Inc | 0.78 | -94.96% |
| MBAI | CheckCap Ltd | 2.88 | -81.37% |
| QGEN | Qiagen NV | 17.55 | +13.41% |
| IQV | IQVIA Holdings Inc | 20.25 | +30.88% |
| DGX | Quest Diagnostics Inc | 21.62 | +39.73% |
| LH | Laboratory Corp Of America Holdings | 22.66 | +46.47% |
| A | Agilent Technologies Inc | 25.45 | +64.48% |
| MEDP | Medpace Holdings Inc | 26.32 | +70.13% |
| TMO | Thermo Fisher Scientific Inc | 26.87 | +73.67% |
| MTD | Mettler-Toledo International Inc | 26.96 | +74.25% |
| DHR | Danaher Corp | 33.26 | +114.94% |
| ILMN | Illumina Inc | 34.97 | +126.03% |
| ICLR | Icon Plc | 39.55 | +155.59% |
| IDXX | Idexx Laboratories Inc | 40.14 | +159.40% |
| VCYT | Veracyte Inc | 40.15 | +159.52% |
| RVTY | Revvity Inc | 45.79 | +195.96% |
| SHC | Sotera Health Company | 63.43 | +309.95% |
| WAT | Waters Corp | 93.81 | +506.29% |